Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The blood in systemic disorders.

J L Spivak1

  • 1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. jlspivak@mail.jhmi.edu

Lancet (London, England)
|July 25, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The third International Congress on Myeloproliferative and Myelodysplastic Syndromes.

Leukemia research·2006
Same author

The second international congress on myeloproliferative and myelodysplastic syndromes.

Leukemia research·2004
Same author

Erythropoietin use and abuse: When physiology and pharmacology collide.

Advances in experimental medicine and biology·2002
Same author

A mail survey of United States hematologists and oncologists: a comparison of business reply versus stamped return envelopes.

Journal of clinical epidemiology·2001
Same author

Current thinking and treatment practices in anaemia--an interactive poll.

Medical oncology (Northwood, London, England)·2001
Same author

A novel thrombopoietin signaling defect in polycythemia vera platelets.

Stem cells (Dayton, Ohio)·2000
Same journal

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Lancet (London, England)·2026
Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026
Same journal

Efficacy and safety of tirofiban after successful endovascular reperfusion in acute ischaemic stroke (ATTRACTION) in China: a multicentre, double-blind, randomised controlled trial.

Lancet (London, England)·2026
See all related articles

Bone marrow

Area of Science:

  • Hematology
  • Internal Medicine
  • Pathophysiology

Background:

  • Bone marrow's high proliferation rate makes it vulnerable to external factors.
  • Anemia is a common hematological abnormality in systemic disorders.
  • Understanding anemia's diverse causes is crucial for effective management.

Purpose of the Study:

  • To review the multifaceted causes of anemia in systemic diseases.
  • To highlight the role of erythropoietin and endocrine factors.
  • To discuss anemia associated with chronic disease, infection, and malignancy.

Main Methods:

  • Literature review of anemia in systemic disorders.
  • Analysis of pathophysiological mechanisms.
  • Evaluation of treatment responses.

Related Experiment Videos

Main Results:

  • Anemia of chronic disease involves reduced erythropoietin and impaired erythroid progenitor cell proliferation.
  • Endocrine status is critical in normocytic, normochromic anemia.
  • Anemia in infection stems from host, parasite, or treatment factors.
  • Malignancy-associated anemia often responds to erythropoietin therapy, with non-response indicating a poor prognosis.

Conclusions:

  • Anemia in systemic disorders is complex, influenced by disease processes, endocrine function, infection, and malignancy.
  • Erythropoietin therapy is a key consideration, particularly in anemia of chronic disease and malignancy.
  • Addressing underlying conditions is essential for managing anemia effectively.